Ticker: CABA

Company: Cabaletta Bio, Inc.

Person: Catherine Bollard, director

Transaction date: Jan. 21, 2026

Reporting date: Jan. 21, 2026

Average share price: 2.2661

Bought 4405.0 shares for 9982.17